<p>(<b>A</b>) <b>Viable cell analysis</b>. MCF7 cells were treated with vehicles, 0.78, 1.56, 3.125, 6.25,12.5, 25, 50, and 100μM of either B13 or LCL521 for 48h and then MTT assays were performed. The results are expressed as a percentage relative to untreated cells and are presented as means ± st dev. of single experiment with 4 time replicates. (<b>B</b>) <b>Effect of LCL521 on MCF7 cell cycle</b>. MCF7 cells were treated with vehicle or with 1, 2.5, 5, 7.5 and 10 μM LCL521 for 24h. Cells were fixed with 70% ethanol overnight before adding 500μL RNase and PI solution. Samples were kept in the dark for another 45min before the FACS analysis. (n = 4, two times experiments with duplicates in each. * <i>p</i><0.01). Representative flow cytom...
<p>(A). Cell cycle distribution was determined by flow cytometry after PI staining. Representative p...
<p>Briefly, 0.2×10<sup>6</sup> cells were pre-cultured for 48 h in phenol red-free DMEM then exposed...
<p>Both (A) immunocytochemical and (B) flow cytometric analyses showed that treatment with FSK incre...
<p><b>A</b>. Huh7 cells were cultured in DMEM +10%FBS for 24 h. The cells were washed with serum fre...
<p>(A) Structure of Lck inhibitor A-770041. (B) Percent of viable cells of LCL-WT, LCL-FLAG-LMP1 and...
<p>(A) Cell proliferation rate of MCF7S, LCC2 and LCC9 cells was measured by XTT assay in a time-dep...
<p>Cells were treated with LPLI at doses of 0 (control), 1, 2, or 4 J/cm<sup>2</sup> and assayed at ...
<p>(<b>A</b>) MTT-Assay of SW480 and HT29 cells after knockdown of Mcl-1, Bcl-2 and Bcl-x<sub>L</sub...
<p>Cells were treated with 5 mM IPTG, 10 nM ICI 182780, 5 µM FTY720, or serum deprived (serum free) ...
<p><b>Copyright information:</b></p><p>Taken from "Control of the growth of human breast cancer cell...
<p>(<b>A</b>) <sup>3</sup>[H] methylthymidine incorporation of SKOV-3 cells treated with 1 mM 1-D-MT...
Cell viability of MCF7 cells after 48 h treatment with different concentrations of chelidonine was e...
<p>A375-pTRIPZ-shAhR cells with or without DOX induced-AhR knockdown were stained with CFSE and trea...
<p><b>(A)</b> HCT116 cells transduced with shMIF or shCont were cultured for up to 3 days with daily...
<p>(A) The cell viability was assessed at 24, 48 and 72 h after transfected with siRNA and control b...
<p>(A). Cell cycle distribution was determined by flow cytometry after PI staining. Representative p...
<p>Briefly, 0.2×10<sup>6</sup> cells were pre-cultured for 48 h in phenol red-free DMEM then exposed...
<p>Both (A) immunocytochemical and (B) flow cytometric analyses showed that treatment with FSK incre...
<p><b>A</b>. Huh7 cells were cultured in DMEM +10%FBS for 24 h. The cells were washed with serum fre...
<p>(A) Structure of Lck inhibitor A-770041. (B) Percent of viable cells of LCL-WT, LCL-FLAG-LMP1 and...
<p>(A) Cell proliferation rate of MCF7S, LCC2 and LCC9 cells was measured by XTT assay in a time-dep...
<p>Cells were treated with LPLI at doses of 0 (control), 1, 2, or 4 J/cm<sup>2</sup> and assayed at ...
<p>(<b>A</b>) MTT-Assay of SW480 and HT29 cells after knockdown of Mcl-1, Bcl-2 and Bcl-x<sub>L</sub...
<p>Cells were treated with 5 mM IPTG, 10 nM ICI 182780, 5 µM FTY720, or serum deprived (serum free) ...
<p><b>Copyright information:</b></p><p>Taken from "Control of the growth of human breast cancer cell...
<p>(<b>A</b>) <sup>3</sup>[H] methylthymidine incorporation of SKOV-3 cells treated with 1 mM 1-D-MT...
Cell viability of MCF7 cells after 48 h treatment with different concentrations of chelidonine was e...
<p>A375-pTRIPZ-shAhR cells with or without DOX induced-AhR knockdown were stained with CFSE and trea...
<p><b>(A)</b> HCT116 cells transduced with shMIF or shCont were cultured for up to 3 days with daily...
<p>(A) The cell viability was assessed at 24, 48 and 72 h after transfected with siRNA and control b...
<p>(A). Cell cycle distribution was determined by flow cytometry after PI staining. Representative p...
<p>Briefly, 0.2×10<sup>6</sup> cells were pre-cultured for 48 h in phenol red-free DMEM then exposed...
<p>Both (A) immunocytochemical and (B) flow cytometric analyses showed that treatment with FSK incre...